Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 438

Results For "Mark"

5345 News Found

Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting
News | March 25, 2022

Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting

Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment


BSV standardises on Veeva Vault PromoMats to speed content distribution
Digitisation | March 25, 2022

BSV standardises on Veeva Vault PromoMats to speed content distribution

Vault PromoMats helps life sciences companies speed the creation, review, and distribution of compliant content. Built-in digital asset management enables content reuse and reduces spend on promotional materials


CHMP recommends EU approval of Roche’s new combination treatment for large B-cell lymphoma
News | March 25, 2022

CHMP recommends EU approval of Roche’s new combination treatment for large B-cell lymphoma

Recommendation is based on pivotal data from the phase III POLARIX study


SRL Diagnostics launches whole genome sequencing test for Tuberculosis
Clinical Trials | March 24, 2022

SRL Diagnostics launches whole genome sequencing test for Tuberculosis

The test can overcome the time and cost limitations of traditional culture-based drug susceptibility testing as it can more rapidly detect all mutations known to be associated with drug resistance for any TB drug in one step


Seven ways the pharma industry can benefit from tech-driven logistics solutions
Opinion | March 24, 2022

Seven ways the pharma industry can benefit from tech-driven logistics solutions

The next-gen logistics management solutions are making the global supply chains more customer-centric and sustainable


LifeMine Therapeutics and GSK enter drug discovery and development alliance
Biotech | March 24, 2022

LifeMine Therapeutics and GSK enter drug discovery and development alliance

The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules


Lupin receives approval from USFDA for Sildenafil for Oral Suspension
Drug Approval | March 24, 2022

Lupin receives approval from USFDA for Sildenafil for Oral Suspension

The product will be manufactured at Lupin’s facility in Goa, India


USFDA approves Novartis Pluvicto to treat prostrate cancer
Drug Approval | March 24, 2022

USFDA approves Novartis Pluvicto to treat prostrate cancer

USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions


Covovax for teens get DCGI nod
Drug Approval | March 23, 2022

Covovax for teens get DCGI nod

It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D


Pfizer voluntary recall of drugs in the US
News | March 23, 2022

Pfizer voluntary recall of drugs in the US

Voluntary nationwide recall of lots of Accuretic (quinapril HCl/hydrochlorothiazide), quinapril and hydrochlorothiazide tablets, and quinapril HCl/hydrochlorothiazide tablets due to n-nitroso- quinapril content